Rocket Pharmaceuticals (RCKT) Enterprise Value (2015 - 2026)
Rocket Pharmaceuticals' Enterprise Value came in at $90.92 million for Q2 2026, compared with -$7.18 million a year earlier and down 63.1% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Enterprise Value (2015 - 2026) Analysis & Trends
For FY2025, Rocket Pharmaceuticals' Enterprise Value was $191.3 million, down 80.2% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of -41.8% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $965.82 million in FY2024 (-58.0%), $2.3 billion in FY2023 (+92.8%), $1.19 billion in FY2022 (+16.9%) and $1.02 billion in FY2021 (-64.4%).
- The five-year range for quarterly Enterprise Value is -$7.18 million (Q2 2025) to $2.3 billion (Q4 2023).
- Year-over-year, Enterprise Value increased in 1 of the last six quarters, with an average decline of 57.6%.
- The fastest year-over-year change in Enterprise Value over five years came in Q2 2023 (growth of 121.2%), and the weakest in Q3 2025 (a decline of 91.0%).
- Business Quant data shows RCKT's Enterprise Value at $246.26 million (Q1 2026), $191.3 million (Q4 2025) and $129.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Rocket Pharmaceuticals | 283.71 Mn | 283.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.92 Mn |
| Mar 31, 2026 | 246.26 Mn |
| Dec 31, 2025 | 191.30 Mn |
| Sep 30, 2025 | 129.96 Mn |
| Jun 30, 2025 | -7.18 Mn |
| Mar 31, 2025 | 393.85 Mn |
| Dec 31, 2024 | 965.82 Mn |
| Sep 30, 2024 | 1.45 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | 2.11 Bn |
| Dec 31, 2023 | 2.30 Bn |
| Sep 30, 2023 | 1.41 Bn |
| Jun 30, 2023 | 1.29 Bn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 1.19 Bn |
| Sep 30, 2022 | 776.21 Mn |
| Jun 30, 2022 | 584.53 Mn |
| Mar 31, 2022 | 676.72 Mn |
| Dec 31, 2021 | 1.02 Bn |
| Sep 30, 2021 | 1.50 Bn |
API Access
Rocket Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();